The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 16 June 2009, www.theannals.com, DOI 10.1345/aph.1M064.
The Annals of Pharmacotherapy: Vol. 43, No. 7, pp. 1347-1353. DOI 10.1345/aph.1M064
© 2009 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Google Scholar
Right arrow Articles by Yamreudeewong, W.
Right arrow Articles by Pulley, K. R
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamreudeewong, W.
Right arrow Articles by Pulley, K. R

Probable Interaction Between Warfarin and Marijuana Smoking

Weeranuj Yamreudeewong, PharmD BCPS CACP

Professor of Pharmacy Practice, School of Pharmacy, University of Wyoming; Clinical Pharmacy Coordinator, Pharmacy Service, Cheyenne Veterans Affairs Medical Center, Cheyenne, WY

Hing Ka Wong, PharmD

Pharmacy Practice Resident, Pharmacy Service, Cheyenne Veterans Affairs Medical Center

Laura M Brausch, MD

Hospitalist/Staff Physician/Pulmonologist, Medicine Service, Cheyenne Veterans Affairs Medical Center

Keri R Pulley, FNP

Nurse Practitioner, Medicine Service, Cheyenne Veterans Affairs Medical Center

Reprints: Dr. Yamreudeewong, Pharmacy Service, Cheyenne Veterans Affairs Medical Center, 2360 E. Pershing Blvd., Cheyenne, WY 82001, fax 307/778-7588, mui111{at}uwyo.edu

OBJECTIVE: To report a probable interaction between warfarin and marijuana smoking, resulting in increased international normalized ratio (INR) values and bleeding complications.

CASE SUMMARY: A 56-year-old white male had been receiving chronic warfarin therapy for 11 years after mechanical heart valve replacement. He was admitted to the hospital with a diagnosis of upper gastrointestinal bleeding. Upon admission, his INR value was supratherapeutic at 10.41, and his hemoglobin level was 6.6 g/dL. He received 4 units of fresh frozen plasma and one 10-mg dose of oral vitamin K; his INR was 1.8 the next day. He was discharged 7 days after admission. Fifteen days after hospital discharge, he was readmitted with a constant nosebleed and increased bruising. His INR value was 11.55. After treatment, he was discharged with an INR value of 1.14. The patient smoked marijuana more frequently throughout the period of these 2 hospitalizations due to his depression. He was counseled by the pharmacist on the potential interaction of warfarin and marijuana. The patient decided to stop smoking marijuana after the third counseling session. During the 9 months that he did not smoke marijuana, his INR values ranged from 1.08 to 4.40 with no significant bleeding complications.

DISCUSSION: Marijuana may increase warfarin anticoagulant effect by inhibiting its metabolism, and to a lesser extent, displacing warfarin from protein-binding sites. Other causes (eg, nonadherence) of the patient's increased INR were ruled out. Using the Horn Drug Interaction Probability Scale, our patient's warfarinmarijuana interaction appeared to be probable.

CONCLUSIONS: To our knowledge, there have been no other reported cases of warfarin-marijuana interaction. While more clinical reports would be useful to confirm this interaction, clinicians should be aware of its probability so as to manage patients appropriately.

Key Words: interaction, international normalized ratio, marijuana, warfarin

Published Online, June 16, 2009. www.theannals.com, DOI 10.1345/aph.1M064





homecopy help contact us subscription past issues search current issue
Copyright © 2009 by Harvey Whitney Books Company.